You just read:

ESSA Pharma Announces Results from the Phase 1 Clinical Trial of EPI-506 for Treatment of mCRPC and Updates Clinical and Strategic Plans

News provided by

ESSA Pharma Inc

Sep 11, 2017, 07:30 ET